IMPACT (Improving Plasma Collection) Clinical Trial — IMPACT

Apheresis Related Hypotension Clinical Trial

Official title:
Prospective, Randomized, Controlled, Multicenter Clinical Trial to Demonstrate the Safety and Effectiveness of the NexSys® PCS Plasma Collection System With the Percent Plasma Nomogram (PPN) Feature

Status Completed

Clinical Trial Summary

Prospective, multi-center, randomized, controlled clinical trial to study the safety and effectiveness of a novel plasma collection system software.

Clinical Trial Description

Prospective, multi-center, randomized, controlled clinical trial that will be conducted at three source plasma collection centers throughout the United States. The objective of the trial is to study the safety and effectiveness of a novel plasma collection nomogram run on the bi-directionally integrated Haemonetics NexSys PCS® and Haemonetics NexLynk DMS® plasma collection system. Subjects will be randomized into an intervention and control arm. The control arm will donate plasma using the current software. The intervention arm will donate plasma using a novel software that supports a more individualized collection approach. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04320823
Study type	Interventional
Source	Haemonetics Corporation
Contact
Status	Completed
Phase	N/A
Start date	January 6, 2020
Completion date	April 27, 2020

View Details